IMS Strengthens Payer Capabilities with Acquisition of Med-Vantage

Software Provider Brings Leading Technology Platform, Clinical Expertise and Proven Provider and Member Engagement Solutions

NORWALK, Conn.--(BUSINESS WIRE)-- IMS Health has acquired Med-Vantage, a San Francisco-based software solutions company, to further expand its presence and capabilities in the payer marketplace. Med-Vantage offers its clients a comprehensive suite of provider performance management and member engagement solutions that promote high-quality care and address the complexities of new reimbursement and care delivery models. IMS will integrate its unique healthcare data, analytics, benchmarks and quality measures into Med-Vantage’s proven suite of payer solutions. This combination will enable payers to proactively engage providers and members with objective information and analysis to change behaviors and create more transparent, clinically grounded performance management programs.

“Med-Vantage is highly valued by clients as an innovative, flexible partner with a robust, extendable payer technology platform,” said Dan Malloy, vice president, IMS Payer Solutions. “We will continue to build on their strong client service culture and leverage their development capabilities to help drive the next generation of innovative health plan offerings.”

IMS Payer Solutions provides comprehensive provider and de-identified patient insights, clinical benchmarks and analytical services to more than 50 health plan and pharmacy benefit management clients. In its services, IMS leverages the largest non-plan-owned integrated medical claims database with more than 70 million lives and the most comprehensive pharmacy data platform covering three-quarters of all prescription activity in the U.S. IMS’s proprietary suite of evidence-based quality metrics drives performance programs for both primary care and complex specialty and hospital care.

“We’re truly excited about the opportunity to join IMS at such a crucial time, as payers are transforming their provider management models and recognizing the need for more innovative analytics to guide these efforts,” said Michael Bodenstab, Med-Vantage vice president of Finance and Strategy. “IMS shares our vision of building a leading analytics company in the payer space and is committed to growing this part of its business. Together, we will be a stronger, more valuable organization to our clients.”

Founded in 2001, Med-Vantage was formed and majority owned by BP Informatics, a consortium of Blue Cross and Blue Shield licensees. Med-Vantage solutions are used by health plans managing more than 30 million lives. Additional information is available at http://www.medvantage.com.

About IMS Health

IMS Health is the leading provider of information services for the healthcare industry around the world. The company draws on its global technology infrastructure and unique combination of in-depth, sophisticated analytics, on-shore and off-shore commercial services, and consulting platforms to help clients better understand the performance and value of medicines. With a presence in 100+ countries and more than 55 years of industry experience, IMS serves leading decision makers in healthcare, including pharmaceutical manufacturers and distributors, providers, payers, government agencies, policymakers, researchers and the financial community. Additional information is available at http://www.imshealth.com.



CONTACT:

IMS Health
Gary Gatyas, +1-610-244-2600
[email protected]

KEYWORDS:   United States  North America  Connecticut

INDUSTRY KEYWORDS:   Technology  Data Management  Software  Health  Hospitals  Professional Services  Finance  Insurance  General Health

MEDIA:

Suggested Articles

The profit margins and management of Community Health Group raise questions about oversight of managed care insurers.

Financial experts are warning practices about the pitfalls of promoting medical credit cards to their patients.

A proposed rule issued by HHS on Tuesday would expand short-term coverage, a move Seema Verma said will have "virtually no impact" on ACA premiums.